Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04723056 · ClinicalTrials.gov registry record · NA
Zemedy Application for Irritable Bowel Syndrome
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 21
- Enrollment target
NCT04723056: Clinical Trial NA study, sponsored by Stanford University.
NCT04723056 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04723056, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
Study Summary
The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.
Interventions
- DEVICE Use of Zemedy Application
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-10-15 |
| Est. Completion | 2024-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04723056
The ClinicalTrials.gov registry entry for NCT04723056 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Use of Zemedy Application is the first listed.
NCT04723056 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04723056 about?
NCT04723056 is a clinical study titled "Zemedy Application for Irritable Bowel Syndrome". The purpose of the study is investigate the effectiveness of Zemedy, a mobile application that enables the digital delivery of a CBT program to people with IBS.
What is the current status of trial NCT04723056?
This trial is currently terminated. It is a NA study. The enrollment target is 21 participants. The study started on 2021-10-15. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT04723056?
The interventions under investigation include: Use of Zemedy Application (DEVICE).
Who is sponsoring clinical trial NCT04723056?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.